Orthopedic Treatment
Our PRP technology is engineered to harness 9 major classes of essential growth factors found within highly concentrated platelets. These factors act as biological engines to trigger cell migration, differentiation, proliferation, and angiogenesis (the formation of new blood vessels).
Autologous Thrombin (ATS)
Through a proprietary patented process, we extract Autologous Thrombin, which serves two critical functions:
-
Extended Bioactivity: Significantly prolongs the preservation and release time of growth factors.
-
Structural Scaffolding: Promotes the aggregation of Fibrinogen to form a biological fibrin scaffold, providing a stable environment for tissue regeneration.
| Feature | Clinical Advantage | Evidence |
|---|---|---|
| Autologous |
100% derived from the patient's own peripheral blood, eliminating any risk of allergic reactions or immune rejection |
Excellent clinical safety profile |
| Point of Care | Requires only a small volume of blood (8–10mL) and allows for rapid preparation | High-efficiency platelet recovery rate |
| Activation and preservation |
Activated using autologous thrombin to achieve a sustained-release effect for therapeutic growth factors |
Significant increase in growth factor concentration |
| Closed System | A physical barrier isolates red blood cells (RBCs) to ensure maximum purity | Removes >98% of Red Blood Cells (RBCs) |